Justin Legleiter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Justin Legleiter has a total of 208 co-authors. Here are the top co-authors by number of shared publications:
Kathleen A. Burke
The C. Eugene Bennett Department of Chemistry, West Virginia University, Morgantown, West Virginia 26505, United States
12 shared publicationsMaxmore Chaibva
C. Eugene Bennett Department of Chemistry, West Virginia University, 100 Prospect Street, Morgantown, West Virginia 26506, United States
11 shared publications- Stephen J. Valentine
University of Louisville
11 shared publications - Tomasz Kowalewski
Department of Chemistry, Carnegie Mellon University, 4400 Fifth Avenue, Pittsburgh, Pennsylvania 15213, United States
9 shared publications - Elizabeth Anne Yates
Department of Chemistry, United States Naval Academy, 572M Holloway Road, Annapolis, Maryland 21402, United States
7 shared publications Faezeh Sedighi
The C. Eugene Bennett Department of Chemistry, West Virginia University
7 shared publications
Latest Publications
- 4 November 2026
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 65 (22) , 3657-3668
N-n-Propylnorapomorphine Inhibits Huntingtin Aggregation and Lipid Membrane Interactions
Aggregation of mutant huntingtin (HTT) contributes to Huntington’s disease (HD) pathogenesis. Lipid membranes strongly influence this process and can also be damaged by membrane-associated HTT species. N–n-propylnorapomorphine (NPA), an aporphine-derived dopamine agonist, was identified in a polydiacetylene (PDA)-based screen for compounds that reduce HTT-exon1-induced perturbation of lipid vesicles. Here, thioflavin T fluorescence assays, ex situ and in situ atomic force microscopy (AFM), lipid-vesicle binding assays, and supported-lipid-bilayer imaging were used to determine how NPA affects HTT aggregation and membrane interactions. In bulk solution, NPA reduced β-sheet-rich fibril formation in a dose-dependent manner, with high concentrations nearly abolishing fibril growth. AFM imaging further showed that NPA suppresses fibril formation while altering the oligomer morphology and heterogeneity. NPA also destabilized preformed HTT fibrils and suppressed the surface-mediated aggregation of an HTT-derived peptide. Importantly, NPA retained inhibitory activity in the presence of lipid vesicles that either suppressed or accelerated HTT aggregation. NPA reduced HTT association with lipid vesicles in a dose-dependent manner and markedly decreased HTT-induced disruption of supported brain lipid bilayers. Collectively, these observations are consistent with NPA acting at multiple, potentially connected stages of the HTT aggregation pathway by altering early assemblies, destabilizing fibrils, and reducing the formation or persistence of membrane-active species. The present data do not distinguish whether these effects arise from a single shared binding mode or from interactions with multiple HTT conformational states. Although its dopamine agonist activity may limit direct therapeutic application, NPA provides a useful proof-of-concept scaffold for compounds targeting both HTT aggregation and membrane-associated toxicity.
- 4 November 2026
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 65 (22) , 3657-3668
N-n-Propylnorapomorphine Inhibits Huntingtin Aggregation and Lipid Membrane Interactions
Aggregation of mutant huntingtin (HTT) contributes to Huntington’s disease (HD) pathogenesis. Lipid membranes strongly influence this process and can also be damaged by membrane-associated HTT species. N–n-propylnorapomorphine (NPA), an aporphine-derived dopamine agonist, was identified in a polydiacetylene (PDA)-based screen for compounds that reduce HTT-exon1-induced perturbation of lipid vesicles. Here, thioflavin T fluorescence assays, ex situ and in situ atomic force microscopy (AFM), lipid-vesicle binding assays, and supported-lipid-bilayer imaging were used to determine how NPA affects HTT aggregation and membrane interactions. In bulk solution, NPA reduced β-sheet-rich fibril formation in a dose-dependent manner, with high concentrations nearly abolishing fibril growth. AFM imaging further showed that NPA suppresses fibril formation while altering the oligomer morphology and heterogeneity. NPA also destabilized preformed HTT fibrils and suppressed the surface-mediated aggregation of an HTT-derived peptide. Importantly, NPA retained inhibitory activity in the presence of lipid vesicles that either suppressed or accelerated HTT aggregation. NPA reduced HTT association with lipid vesicles in a dose-dependent manner and markedly decreased HTT-induced disruption of supported brain lipid bilayers. Collectively, these observations are consistent with NPA acting at multiple, potentially connected stages of the HTT aggregation pathway by altering early assemblies, destabilizing fibrils, and reducing the formation or persistence of membrane-active species. The present data do not distinguish whether these effects arise from a single shared binding mode or from interactions with multiple HTT conformational states. Although its dopamine agonist activity may limit direct therapeutic application, NPA provides a useful proof-of-concept scaffold for compounds targeting both HTT aggregation and membrane-associated toxicity.
- 29 June 2026
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 25 (8) , 3845-3860
Proteomic Impact of Peripheral Expression of Mutant Huntingtin in C. elegans
Huntington’s Disease (HD), a neurodegenerative disorder, is caused by the expansion of a polyglutamine (polyQ) tract near the N-terminus of the huntingtin protein (HTT), resulting in HTT aggregation. While associated with neurodegeneration, HTT is expressed ubiquitously throughout the body, leading to potential peripheral consequences of aggregation. However, the impact on peripheral tissues remains poorly understood in comparison to the central nervous system. Here, a Caenorhabditis elegans (C. elegans) HD model that expresses an N-terminal HTT fragment (nonpathogenic 15Q or pathogenic 128Q) in body-wall muscle cells was used to evaluate proteome remodeling. Four conditions (15Q and 128Q on days 2 and 7 of adult worms, denoted as 15D2, 15D7, 128D2, and 128D7) were evaluated. In comparison to 15D2, 128D2 worms displayed decreased expression of ribosomal proteins and cytoskeletal components such as actin, profilin, calponin, and myosin, as well as overexpression of galectin, a stress- and inflammation-associated protein. By day 7, the 15D7 animals exhibited developmental signatures related to ribosome biogenesis, signal transduction, and vesicle trafficking, whereas abundance levels of proteins associated with stress response pathways such as proteostasis, protein folding, and cytoskeletal remodeling were observed to be increased in the 128D7 worms. These findings demonstrate the stage-dependent, nonlinear nature of HD-associated proteome disruption associated with peripheral expression of HD.
- 29 June 2026
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 25 (8) , 3845-3860
Proteomic Impact of Peripheral Expression of Mutant Huntingtin in C. elegans
Huntington’s Disease (HD), a neurodegenerative disorder, is caused by the expansion of a polyglutamine (polyQ) tract near the N-terminus of the huntingtin protein (HTT), resulting in HTT aggregation. While associated with neurodegeneration, HTT is expressed ubiquitously throughout the body, leading to potential peripheral consequences of aggregation. However, the impact on peripheral tissues remains poorly understood in comparison to the central nervous system. Here, a Caenorhabditis elegans (C. elegans) HD model that expresses an N-terminal HTT fragment (nonpathogenic 15Q or pathogenic 128Q) in body-wall muscle cells was used to evaluate proteome remodeling. Four conditions (15Q and 128Q on days 2 and 7 of adult worms, denoted as 15D2, 15D7, 128D2, and 128D7) were evaluated. In comparison to 15D2, 128D2 worms displayed decreased expression of ribosomal proteins and cytoskeletal components such as actin, profilin, calponin, and myosin, as well as overexpression of galectin, a stress- and inflammation-associated protein. By day 7, the 15D7 animals exhibited developmental signatures related to ribosome biogenesis, signal transduction, and vesicle trafficking, whereas abundance levels of proteins associated with stress response pathways such as proteostasis, protein folding, and cytoskeletal remodeling were observed to be increased in the 128D7 worms. These findings demonstrate the stage-dependent, nonlinear nature of HD-associated proteome disruption associated with peripheral expression of HD.
- 23 September 2025
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 16 (20) , 4037-4049
Exogenous Huntingtin-Exon1 Aggregates Exhibit Distinct Levels of Toxicity to Caenorhabditis elegans
Many neurodegenerative diseases, including Alzheimer's (AD), Parkinson's (PD), and Huntington's disease (HD), are associated with proteinaceous deposits in the brain comprising amyloid. The aggregation process leading to these deposits proceeds through a variety of intermediates, i.e., oligomers and fibrils. The heterogeneity of aggregates produced complicates the assignment of specific toxic functions to distinct aggregate species. Here, a simple centrifugation strategy was employed to produce well-characterized and relatively homogeneous populations of huntingtin (htt) aggregates in vitro. After characterization of the resulting aggregate populations, C. elegans were exogenously exposed to these different aggregates species to assess their impact on worm viability. Htt oligomers were identified as the most acutely toxic aggregate form. Nonaggregated htt and fibrils did not significantly reduce C. elegans viability. A variety of methods to manipulate htt oligomers were then tested to demonstrate the ability to modify oligomer toxicity in this model system. Chemically cross-linking htt oligomers reduced their toxicity, suggesting that structural flexibility is important in oligomer toxicity. Stabilizing oligomers with truncated peptides based on the first 17 N-terminal amino acids (Nt17) impacted toxicity when specific acetylation-mimicking point mutations were introduced. Nt17-derived peptides without any mutations did not alter toxicity; however, the addition of acetylation-mimicking mutations toward the C-terminus of the peptide reduces toxicity. Finally, two small molecules that modify htt aggregation, EGCG and riluzole, were tested for their impact on oligomer toxicity. In general, this approach provides a simple method to investigate and manipulate the toxicity of aggregate subpopulation in a quasi-controlled manner.
- 23 September 2025
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 16 (20) , 4037-4049
Exogenous Huntingtin-Exon1 Aggregates Exhibit Distinct Levels of Toxicity to Caenorhabditis elegans
Many neurodegenerative diseases, including Alzheimer's (AD), Parkinson's (PD), and Huntington's disease (HD), are associated with proteinaceous deposits in the brain comprising amyloid. The aggregation process leading to these deposits proceeds through a variety of intermediates, i.e., oligomers and fibrils. The heterogeneity of aggregates produced complicates the assignment of specific toxic functions to distinct aggregate species. Here, a simple centrifugation strategy was employed to produce well-characterized and relatively homogeneous populations of huntingtin (htt) aggregates in vitro. After characterization of the resulting aggregate populations, C. elegans were exogenously exposed to these different aggregates species to assess their impact on worm viability. Htt oligomers were identified as the most acutely toxic aggregate form. Nonaggregated htt and fibrils did not significantly reduce C. elegans viability. A variety of methods to manipulate htt oligomers were then tested to demonstrate the ability to modify oligomer toxicity in this model system. Chemically cross-linking htt oligomers reduced their toxicity, suggesting that structural flexibility is important in oligomer toxicity. Stabilizing oligomers with truncated peptides based on the first 17 N-terminal amino acids (Nt17) impacted toxicity when specific acetylation-mimicking point mutations were introduced. Nt17-derived peptides without any mutations did not alter toxicity; however, the addition of acetylation-mimicking mutations toward the C-terminus of the peptide reduces toxicity. Finally, two small molecules that modify htt aggregation, EGCG and riluzole, were tested for their impact on oligomer toxicity. In general, this approach provides a simple method to investigate and manipulate the toxicity of aggregate subpopulation in a quasi-controlled manner.
- 10 September 2025
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 50 (11) , 1015-1026
Membranes as targets and modifiers of mutant huntingtin aggregation
- 10 September 2025
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 50 (11) , 1015-1026
Membranes as targets and modifiers of mutant huntingtin aggregation
- 6 August 2025
- Published by American Chemical Society (ACS) in Biochemistry
Amyloidogenic SARS-CoV-2 Spike Protein-Derived Peptides Form Oligomers and Selectively Damage Lipid Membranes
Several peptides derived from the SARS-CoV-2 spike protein (S-protein) are amyloidogenic, suggesting a potential role in COVID-19 disease-associated pathogenesis. Many disease-related amyloids form a variety of intermediate oligomeric aggregates and directly damage lipid membranes. Gain of toxic function is commonly observed for oligomeric and fibrillar aggregates of amyloid peptides. Therefore, the ability of four S-protein-derived peptides (s192, s258, s601, and s1166) to form oligomers and fibrils was investigated. Additionally, their ability to bind and damage lipid membranes was also determined. Using ThT assays, time points before and after fibril nucleation were chosen for each peptide to explore aggregate morphologies. At early time points, each peptide formed oligomers with unique morphological characteristics. Fibril morphologies of each peptide varied as well, with s601 and s1166 forming two distinct fibril morphologies that coexisted. When supported total brain lipid extract (TBLE) bilayers were exposed to S-protein-derived peptides and tracked via in situ AFM, only s192 progressively bound to and damaged the membrane. Oligomers of s1166 formed on TBLE bilayers but did not visibly disrupt the bilayer. Both the s258 and s601 minimally (if at all) interacted with the bilayers. No fibrils were observed on the bilayers from any of the peptides. The addition of Ca2+ to the assay reduced the ability of all peptides to bind to TBLE bilayers. As oligomer toxicity and membrane damage are common features of amyloid-based diseases, these results open the possibility that similar molecular mechanisms associated with the endoproteolysis of the SARS-CoV-2 S-protein may contribute to COVID-19.
- 6 August 2025
- Published by American Chemical Society (ACS) in Biochemistry
Amyloidogenic SARS-CoV-2 Spike Protein-Derived Peptides Form Oligomers and Selectively Damage Lipid Membranes
Several peptides derived from the SARS-CoV-2 spike protein (S-protein) are amyloidogenic, suggesting a potential role in COVID-19 disease-associated pathogenesis. Many disease-related amyloids form a variety of intermediate oligomeric aggregates and directly damage lipid membranes. Gain of toxic function is commonly observed for oligomeric and fibrillar aggregates of amyloid peptides. Therefore, the ability of four S-protein-derived peptides (s192, s258, s601, and s1166) to form oligomers and fibrils was investigated. Additionally, their ability to bind and damage lipid membranes was also determined. Using ThT assays, time points before and after fibril nucleation were chosen for each peptide to explore aggregate morphologies. At early time points, each peptide formed oligomers with unique morphological characteristics. Fibril morphologies of each peptide varied as well, with s601 and s1166 forming two distinct fibril morphologies that coexisted. When supported total brain lipid extract (TBLE) bilayers were exposed to S-protein-derived peptides and tracked via in situ AFM, only s192 progressively bound to and damaged the membrane. Oligomers of s1166 formed on TBLE bilayers but did not visibly disrupt the bilayer. Both the s258 and s601 minimally (if at all) interacted with the bilayers. No fibrils were observed on the bilayers from any of the peptides. The addition of Ca2+ to the assay reduced the ability of all peptides to bind to TBLE bilayers. As oligomer toxicity and membrane damage are common features of amyloid-based diseases, these results open the possibility that similar molecular mechanisms associated with the endoproteolysis of the SARS-CoV-2 S-protein may contribute to COVID-19.
- Open Access
- 13 November 2024
- Published by American Chemical Society (ACS) in ACS Physical Chemistry Au
- Vol. 5 (1) , 17-29
Structure Characterization of a Disordered Peptide Using In-Droplet Hydrogen/Deuterium Exchange Mass Spectrometry and Molecular Dynamics
In-droplet hydrogen/deuterium exchange (HDX)-mass spectrometry (MS) experiments have been conducted for peptides of highly varied conformational type. A new model is presented that combines the use of protection factors (PF) from molecular dynamics (MD) simulations with intrinsic HDX rates (k int) to obtain a structure-to-reactivity calibration curve. Using the model, the relationship of peptide structural flexibility and HDX reactivity for different peptides is elucidated. Additionally, the model is used to describe the degree of conformational flexibility and structural bias for the disease-relevant Nt17 peptide; although highly flexible, intrinsically primed for facile conversion to α-helical conformation upon binding with molecular partners imparts significant in-droplet HDX protection for this peptide. In the future, a scale may be developed whereby HDX reactivity is predictive of the degree of structural flexibility and bias (propensity to form 2° structural elements such as α-helix, β-sheet, and β-turn) for intrinsically disordered regions (IDRs). Such structural resolution may ultimately be used for high-throughput screening of IDR structural transformation(s) upon binding of ligands such as drug candidates.
- 13 November 2024
- Published by American Chemical Society (ACS) in ACS Physical Chemistry Au
- Vol. 5 (1) , 17-29
Open AccessStructure Characterization of a Disordered Peptide Using In-Droplet Hydrogen/Deuterium Exchange Mass Spectrometry and Molecular Dynamics
In-droplet hydrogen/deuterium exchange (HDX)-mass spectrometry (MS) experiments have been conducted for peptides of highly varied conformational type. A new model is presented that combines the use of protection factors (PF) from molecular dynamics (MD) simulations with intrinsic HDX rates (k int) to obtain a structure-to-reactivity calibration curve. Using the model, the relationship of peptide structural flexibility and HDX reactivity for different peptides is elucidated. Additionally, the model is used to describe the degree of conformational flexibility and structural bias for the disease-relevant Nt17 peptide; although highly flexible, intrinsically primed for facile conversion to α-helical conformation upon binding with molecular partners imparts significant in-droplet HDX protection for this peptide. In the future, a scale may be developed whereby HDX reactivity is predictive of the degree of structural flexibility and bias (propensity to form 2° structural elements such as α-helix, β-sheet, and β-turn) for intrinsically disordered regions (IDRs). Such structural resolution may ultimately be used for high-throughput screening of IDR structural transformation(s) upon binding of ligands such as drug candidates.
- Open Access
Blocking the ability of huntingtin to bind membranes: a therapeutic strategy for Huntington’s disease
The ordered aggregation of proteins into amyloid fibrils is a hallmark of numerous neurodegenerative diseases. A common strategy in developing therapeutics for amyloid-based diseases relies on preventing or manipulating the aggregation process. However, many amyloid-forming proteins and their aggregates bind and damage organelle and cellular membranes. As such, blocking the ability of these proteins from directly interacting with membranes represents a unique therapeutic strategy. Using a mutant huntingtin (htt) protein associated with Huntington’s disease (HD) as a model system, the viability of this strategy was evaluated. Screening over 1200 compounds for their ability to block htt binding to lipid vesicles, two compounds, Ro90-7501 (Ro) and Benzamil (Ben), were identified and validated. Despite directly interacting with htt, neither compound prevented fibril formation. Molecular dynamics simulations suggested each compound has a unique mechanism of action, consistent with experimental data. Importantly, both compounds ameliorated phenotype in a C. elegans model of HD.
Open AccessBlocking the ability of huntingtin to bind membranes: a therapeutic strategy for Huntington’s disease
The ordered aggregation of proteins into amyloid fibrils is a hallmark of numerous neurodegenerative diseases. A common strategy in developing therapeutics for amyloid-based diseases relies on preventing or manipulating the aggregation process. However, many amyloid-forming proteins and their aggregates bind and damage organelle and cellular membranes. As such, blocking the ability of these proteins from directly interacting with membranes represents a unique therapeutic strategy. Using a mutant huntingtin (htt) protein associated with Huntington’s disease (HD) as a model system, the viability of this strategy was evaluated. Screening over 1200 compounds for their ability to block htt binding to lipid vesicles, two compounds, Ro90-7501 (Ro) and Benzamil (Ben), were identified and validated. Despite directly interacting with htt, neither compound prevented fibril formation. Molecular dynamics simulations suggested each compound has a unique mechanism of action, consistent with experimental data. Importantly, both compounds ameliorated phenotype in a C. elegans model of HD.
- 17 May 2024
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1866 (6) , 184339
Divalent cations promote huntingtin fibril formation on endoplasmic reticulum derived and model membranes
- 17 May 2024
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1866 (6) , 184339
Divalent cations promote huntingtin fibril formation on endoplasmic reticulum derived and model membranes
- Open Access
- 14 March 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (3) , e0298323
The polyglutamine domain is the primary driver of seeding in huntingtin aggregation
Huntington’s Disease (HD) is a fatal, neurodegenerative disease caused by aggregation of the huntingtin protein (htt) with an expanded polyglutamine (polyQ) domain into amyloid fibrils. Htt aggregation is modified by flanking sequences surrounding the polyQ domain as well as the binding of htt to lipid membranes. Upon fibrillization, htt fibrils are able to template the aggregation of monomers into fibrils in a phenomenon known as seeding, and this process appears to play a critical role in cell-to-cell spread of HD. Here, exposure of C. elegans expressing a nonpathogenic N-terminal htt fragment (15-repeat glutamine residues) to preformed htt-exon1 fibrils induced inclusion formation and resulted in decreased viability in a dose dependent manner, demonstrating that seeding can induce toxic aggregation of nonpathogenic forms of htt. To better understand this seeding process, the impact of flanking sequences adjacent to the polyQ stretch, polyQ length, and the presence of model lipid membranes on htt seeding was investigated. Htt seeding readily occurred across polyQ lengths and was independent of flanking sequence, suggesting that the structured polyQ domain within fibrils is the key contributor to the seeding phenomenon. However, the addition of lipid vesicles modified seeding efficiency in a manner suggesting that seeding primarily occurs in bulk solution and not at the membrane interface. In addition, fibrils formed in the presence of lipid membranes displayed similar seeding efficiencies. Collectively, this suggests that the polyQ domain that forms the amyloid fibril core is the main driver of seeding in htt aggregation.
- 14 March 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (3) , e0298323
Open AccessThe polyglutamine domain is the primary driver of seeding in huntingtin aggregation
Huntington’s Disease (HD) is a fatal, neurodegenerative disease caused by aggregation of the huntingtin protein (htt) with an expanded polyglutamine (polyQ) domain into amyloid fibrils. Htt aggregation is modified by flanking sequences surrounding the polyQ domain as well as the binding of htt to lipid membranes. Upon fibrillization, htt fibrils are able to template the aggregation of monomers into fibrils in a phenomenon known as seeding, and this process appears to play a critical role in cell-to-cell spread of HD. Here, exposure of C. elegans expressing a nonpathogenic N-terminal htt fragment (15-repeat glutamine residues) to preformed htt-exon1 fibrils induced inclusion formation and resulted in decreased viability in a dose dependent manner, demonstrating that seeding can induce toxic aggregation of nonpathogenic forms of htt. To better understand this seeding process, the impact of flanking sequences adjacent to the polyQ stretch, polyQ length, and the presence of model lipid membranes on htt seeding was investigated. Htt seeding readily occurred across polyQ lengths and was independent of flanking sequence, suggesting that the structured polyQ domain within fibrils is the key contributor to the seeding phenomenon. However, the addition of lipid vesicles modified seeding efficiency in a manner suggesting that seeding primarily occurs in bulk solution and not at the membrane interface. In addition, fibrils formed in the presence of lipid membranes displayed similar seeding efficiencies. Collectively, this suggests that the polyQ domain that forms the amyloid fibril core is the main driver of seeding in htt aggregation.
- Open Access
- 13 February 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Structure Characterization of a Disordered Peptide Using In-Droplet Hydrogen Deuterium Exchange Mass Spectrometry and Molecular Dynamics
The highly dynamic nature of intrinsically disordered proteins (IDPs), those containing intrinsically disordered regions (IDRs), makes their structural characterization very difficult using traditional measurement approaches. Especially challenging is the determination of the propensity to form specific types of structure upon interacting with binding partners. Here, the reactivities of select peptides ranging from highly-structured to unstructured species have been examined with in-droplet hydrogen-deuterium exchange (HDX) techniques. Overall, the consideration of intrinsic rates (kint) of exchange for different backbone sites is shown to be a poor predictor of peptide reactivity. Here, we develop a new model for HDX prediction that combines the use of protection factors (PF) from molecular dynamics (MD) simulations with kint to obtain high-accuracy HDX predictability for peptides having various structural types. The relationship of peptide structural flexibility and HDX reactivity for different peptides is elucidated. Additionally, the model is used to characterize the degree of structural bias for the disease-relevant Nt17; although highly flexible, being primed for facile conversion to α-helical conformation upon binding with molecular partners imparts HDX protection. In the future a scale may be developed whereby HDX reactivity is associated with the degree of IDR structural flexibility and bias. Such structural resolution may ultimately be used for high-throughput screening of IDR structural transformation (including structural flexibility and bias) upon binding of drug candidates.
- 13 February 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessStructure Characterization of a Disordered Peptide Using In-Droplet Hydrogen Deuterium Exchange Mass Spectrometry and Molecular Dynamics
The highly dynamic nature of intrinsically disordered proteins (IDPs), those containing intrinsically disordered regions (IDRs), makes their structural characterization very difficult using traditional measurement approaches. Especially challenging is the determination of the propensity to form specific types of structure upon interacting with binding partners. Here, the reactivities of select peptides ranging from highly-structured to unstructured species have been examined with in-droplet hydrogen-deuterium exchange (HDX) techniques. Overall, the consideration of intrinsic rates (kint) of exchange for different backbone sites is shown to be a poor predictor of peptide reactivity. Here, we develop a new model for HDX prediction that combines the use of protection factors (PF) from molecular dynamics (MD) simulations with kint to obtain high-accuracy HDX predictability for peptides having various structural types. The relationship of peptide structural flexibility and HDX reactivity for different peptides is elucidated. Additionally, the model is used to characterize the degree of structural bias for the disease-relevant Nt17; although highly flexible, being primed for facile conversion to α-helical conformation upon binding with molecular partners imparts HDX protection. In the future a scale may be developed whereby HDX reactivity is associated with the degree of IDR structural flexibility and bias. Such structural resolution may ultimately be used for high-throughput screening of IDR structural transformation (including structural flexibility and bias) upon binding of drug candidates.